This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Adrenergic receptor 3D structures
From Proteopedia
(Difference between revisions)
| (4 intermediate revisions not shown.) | |||
| Line 3: | Line 3: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| + | |||
| + | *α-1B adrenergic receptor | ||
| + | |||
| + | **[[7b6w]] – hA1AR + agonist<br /> | ||
*α-2 adrenergic receptor | *α-2 adrenergic receptor | ||
| - | **[[1ho9]], [[1hod]] – hA2AR peptide (mutant) – | + | **[[6kuy]] – hA2AR + partial agonist<br /> |
| - | **[[1hof]], [[1hll]] - hA2AR peptide – NMR<br /> | + | **[[1ho9]], [[1hod]] – hA2AR peptide (mutant) – NMR |
| + | **[[1hof]], [[1hll]] - hA2AR peptide – NMR | ||
| + | **[[6kuw]] – hA2ACR + cholesterol + quinolone derivative<br /> | ||
| + | **[[6k41]], [[6k42]] – hA2AAR/A2BAR + Gunine nucleotide binding protein + scFv – Cryo EM<br /> | ||
| + | **[[7ej0]], [[7ej8]], [[7eja]], [[7ejk]] – hA2AR + Guanine nucleotide binding protein + scFv + drug – Cryo EM<br /> | ||
| + | **[[6kux]] – A2AR + antagonist – ''Spodoptera frugiperda''<br /> | ||
*β-1 adrenergic receptor | *β-1 adrenergic receptor | ||
| + | **[[7bts]] – hB1AR/T4 lysozyme (mutant) + nanobody + epinephrine - human<br /> | ||
| + | **[[7bu6]], [[7bu7]] – hB1AR/endolysin + nanobody + epinephrine derivative<br /> | ||
| + | **[[7bvq]] – hB1AR/endolysin + carazolol<br /> | ||
**[[2y01]], [[4gpo]], [[5f8u]] – tB1AR fragment (mutant) – turkey<br /> | **[[2y01]], [[4gpo]], [[5f8u]] – tB1AR fragment (mutant) – turkey<br /> | ||
**[[1dep]] – tB1AR peptide - NMR<br /> | **[[1dep]] – tB1AR peptide - NMR<br /> | ||
| Line 17: | Line 29: | ||
**[[3zpq]], [[3zpr]] - tB1AR fragment (mutant) + aryl piperazine inhibitor<br /> | **[[3zpq]], [[3zpr]] - tB1AR fragment (mutant) + aryl piperazine inhibitor<br /> | ||
**[[4bvn]] - tB1AR + cyanopindolol<br /> | **[[4bvn]] - tB1AR + cyanopindolol<br /> | ||
| - | **[[6h7j]], [[6h7l]], [[6h7m]], [[6h7n]], [[6h7o]] – tB1AR (mutant) + | + | **[[6h7j]], [[6h7l]], [[6h7m]], [[6h7n]], [[6h7o]], [[6ibl]] – tB1AR (mutant) + nanobody + thioredoxin + agonist<br /> |
| + | **[[7s0f]], [[7s0g]] - tB1AR + guanine nucleotide-binding protein + drug – Cryo EM<br /> | ||
| + | **[[7jjo]] - tB1AR + guanine nucleotide-binding protein + nanobody + drug – Cryo EM<br /> | ||
| + | **[[6tko]] - tB1AR + arrestin + antibody + modulator – Cryo EM<br /> | ||
*β-2 adrenergic receptor | *β-2 adrenergic receptor | ||
| + | **[[6kr8]] - hB2AR<br /> | ||
**[[3pds]] - hB2AR/T4 lysozyme<br /> | **[[3pds]] - hB2AR/T4 lysozyme<br /> | ||
| - | **[[3p0g]] – hB2AR/T4 lysozyme + | + | **[[3p0g]] – hB2AR/T4 lysozyme + nanobody<br /> |
| - | **[[4lde]], [[4ldl]], [[4ldo]] - hB2AR/T4 lysozyme (mutant) + | + | **[[4lde]], [[4ldl]], [[4ldo]] - hB2AR/T4 lysozyme (mutant) + nanobody<br /> |
**[[2r4s]],[[2r4r]] - hB2AR + Fab5 complex<br /> | **[[2r4s]],[[2r4r]] - hB2AR + Fab5 complex<br /> | ||
**[[2rh1]] - hB2AR/T4 lysozyme (mutant)<br /> | **[[2rh1]] - hB2AR/T4 lysozyme (mutant)<br /> | ||
| Line 30: | Line 46: | ||
**[[6mxt]] - hB2AR/T4 lysozyme (mutant) + antibody + salmeterol<br /> | **[[6mxt]] - hB2AR/T4 lysozyme (mutant) + antibody + salmeterol<br /> | ||
**[[5x7d]] - hB2AR/T4 lysozyme (mutant) + carazolol + inhibitor<br /> | **[[5x7d]] - hB2AR/T4 lysozyme (mutant) + carazolol + inhibitor<br /> | ||
| + | **[[6oba]] - hB2AR/T4 lysozyme (mutant) + modulator<br /> | ||
| + | **[[6ps0]], [[6prz]], [[6ps2]], [[6ps3]], [[6ps4]], [[6ps5]], [[6ps6]] - hB2AR + cholesterol + carazolol derivative<br /> | ||
| + | **[[6ps1]] - hB2AR + cholesterol + timolol<br /> | ||
**[[5d5a]], [[5d5b]] - hB2AR (mutant) + cholesterol + carazolol<br /> | **[[5d5a]], [[5d5b]] - hB2AR (mutant) + cholesterol + carazolol<br /> | ||
**[[5jqh]] - hB2AR/T4 lysozyme (mutant) + carazolol + nanobody<br /> | **[[5jqh]] - hB2AR/T4 lysozyme (mutant) + carazolol + nanobody<br /> | ||
**[[3ny8]], [[3ny9]], [[3nya]] – hB2AR/T4 lysozyme + agonist<br /> | **[[3ny8]], [[3ny9]], [[3nya]] – hB2AR/T4 lysozyme + agonist<br /> | ||
| - | **[[3sn6]] - human β-2 adrenergic receptor + | + | **[[6n48]] - hB2AR/endolysin + nanobody + modulator<br /> |
| + | **[[3sn6]] - human β-2 adrenergic receptor + nano body bound by guanine nucleotide-binding protein G<br /> | ||
| + | **[[7bz2]], [[7dhi]], [[7dhr]] – hB2AR + guanine nucleotide-binding protein + nanobody + modulator – Cryo EM<br /> | ||
**[[3kj6]], [[2r4r]], [[2r4s]] – hB2AR + FAB heavy+light chains<br /> | **[[3kj6]], [[2r4r]], [[2r4s]] – hB2AR + FAB heavy+light chains<br /> | ||
**[[4qkx]] – B2AR + R9 protein - llama<br /> | **[[4qkx]] – B2AR + R9 protein - llama<br /> | ||
| + | |||
| + | *β-3 adrenergic receptor | ||
| + | |||
| + | **[[7dh5]], [[7xjh]], a[[7xji]] – B3AR + guanine nucleotide-binding protein + nanobody + drug – dog - Cryo EM<br /> | ||
| + | |||
}} | }} | ||
[[Category: Topic Page]] | [[Category: Topic Page]] | ||
Current revision
3D Structures of Adrenergic receptor
Updated on 12-December-2022
